Cargando…
The Clinical and Economic Impact of the V-Go(®) Disposable Insulin Delivery Device for Insulin Delivery in Patients with Poorly Controlled Diabetes at High Risk
BACKGROUND: Diabetes is a chronic condition and when poorly controlled can lead to complications and death. Patients with glycated hemoglobin (A1C) measures >9 % are at significant risk for diabetes-related complications impacting the patient’s quality of life and imposing higher costs on the hea...
Autores principales: | Lajara, Rosemarie, Nikkel, Carla, Abbott, Scott |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914539/ https://www.ncbi.nlm.nih.gov/pubmed/27398298 http://dx.doi.org/10.1007/s40801-016-0075-4 |
Ejemplares similares
-
Use of V-Go(®) Insulin Delivery Device in Patients with Sub-optimally Controlled Diabetes Mellitus: A Retrospective Analysis from a Large Specialized Diabetes System
por: Lajara, Rosemarie, et al.
Publicado: (2015) -
Clinical Insights Into a New, Disposable Insulin Delivery Device
por: Knutsen, P. Gaye, et al.
Publicado: (2015) -
Regular Insulin Administered With the V-Go Disposable Insulin Delivery Device in a Clinical Diabetes Setting: A Retrospective Analysis of Efficacy and Cost
por: Sutton, David, et al.
Publicado: (2016) -
Clinical Benefits Over Time Associated with Use of V-Go Wearable Insulin Delivery Device in Adult Patients with Diabetes: A Retrospective Analysis
por: Sutton, David, et al.
Publicado: (2018) -
Clinical Evaluation of Basal-Bolus Therapy Delivered by the V-Go(®) Wearable Insulin Delivery Device in Patients with Type 2 Diabetes: A Retrospective Analysis
por: Zeidan, Trisha, et al.
Publicado: (2020)